01.28.26 -- Trump's Big Pharma Deals Drive CDMO Investments

Uncover how innovative reagent selection accelerates the development of promising drug-like molecules in challenging research environments.

Choosing the right packaging partner for your probiotic may be the most crucial step to ensuring your product is safe and potent when it reaches the consumer.

Many growing industries face universal tablet compression challenges, demanding better tooling, tighter process control, and more integrated data to ensure product consistency and reliable scale-up.

With explosive demand, expanding indications, and rapid innovation, the GLP-1 revolution is reshaping dealmaking. Here's a practical guide for companies negotiating M&A in this arena.

As demand for GLP-1s and biologics accelerates, it's become more crucial that pharmaceutical companies stay competitive and bring therapies to market faster by partnering with a CDMO.

Review the optimization of the manufacturing process of a pharmaceutical intermediate, and discover how yield can be improved substantially via suitable reaction engineering.

Integration of robotics and automated systems across laboratory services significantly decreases experimental timelines, tightens precision, and enhances scientists' capacity for critical thinking.

Bringing complex generics to market requires expertise. See how a CDMO can navigate regulatory, technical, and commercial challenges with end-to-end development and manufacturing support.

Poorly soluble compounds require targeted strategies to enhance bioavailability. Key methods include converting the API to an amorphous form, reducing particle size, and using lipid-based vehicles.

A pharma company sought a CMO partner with commercial manufacturing capabilities and expertise as well as exemplary quality systems to find a cost-effective process to produce the API for a new drug.

A global network supports drug programs from discovery to commercial stages with cost-efficient, streamlined outsourcing.

Improve solubility, stability, and speed to clinic for even your toughest APIs. Discover why innovators are relying on Spray Dried Dispersion (SDD) technology.

Our capabilities support the development and cGMP-compliant production of small-molecule active pharmaceutical ingredients (APIs), registered starting materials (RSMs), and advanced intermediates.